130 Participants Needed

Inulin for Traumatic Brain Injury

KR
CD
Overseen ByChristopher Danesi, MS
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: The University of Texas Medical Branch, Galveston
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 6 JurisdictionsThis treatment is already approved in other countries

Trial Summary

What is the purpose of this trial?

The aim of this study is to characterize the microbiome of patients undergoing post-acute residential neurorehabilitation compared to community controls and to determine if a dietary fiber, Inulin, can create a shift in the microbiome leading to changes in fatigue and cognition.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. Please consult with the study team for guidance.

What data supports the effectiveness of the treatment Inulin for Traumatic Brain Injury?

Research shows that inulin, a type of prebiotic fiber, can help improve recovery from mild traumatic brain injury by promoting the growth of beneficial gut bacteria, which in turn can enhance brain health and function. In studies with mice, inulin was found to restore blood flow in the brain and improve brain structure after injury.12345

Is inulin safe for humans?

Inulin, a type of prebiotic fiber, is generally considered safe for humans and has been shown to promote the growth of beneficial gut bacteria and improve bowel function. Studies have found it beneficial for gut health in a wide age range, from infants to the elderly, without significant safety concerns.13467

How does the treatment Inulin differ from other treatments for traumatic brain injury?

Inulin is unique because it targets gut health by promoting beneficial bacteria and increasing short-chain fatty acids, which can help reduce inflammation and improve brain recovery after a traumatic brain injury. Unlike other treatments, it focuses on mitigating gut dysbiosis (imbalance of gut bacteria) to protect brain structure and function, and there are currently no standard treatments for mild traumatic brain injury.148910

Research Team

RU

Randall Urban, MD

Principal Investigator

University of Texas

AD

Ana Durand, MD

Principal Investigator

Moody Neurorehabilitation Institute

Eligibility Criteria

This trial is for individuals in post-acute residential neurorehabilitation after a traumatic brain injury. It's designed to see if their gut bacteria (microbiome) can be altered by a dietary fiber called Inulin, which might help with fatigue and thinking problems.

Inclusion Criteria

Willing and able to provide consent (with LAR if needed)
Have a family member who is admitted to Moody Neurorehabilitation Institute for care OR is working at Moody Neurorehabilitation Institute
My injury occurred less than 6 months ago.
See 5 more

Exclusion Criteria

I have active diverticular disease.
I have not had a stroke in the last 6 months.
Pregnancy or becoming pregnant during the study
See 7 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive daily oral inulin supplementation (4g 2x daily) during inpatient post-acute neurorehabilitation

6 weeks
Regular visits during inpatient stay

Follow-up

Participants are monitored for changes in gut microbiome and neurologic symptoms after discontinuation of inulin

6 months
Periodic assessments at 3 and 6 months

Long-term Follow-up

Participants' fatigue and cognition are assessed using the Fatigue and Altered Cognition Scale

6 months

Treatment Details

Interventions

  • Inulin
Trial Overview The study tests whether taking Inulin, a type of dietary fiber, changes the gut microbiome and improves neurological symptoms like fatigue and cognition in people recovering from traumatic brain injuries.
Participant Groups
3Treatment groups
Active Control
Group I: Community ControlsActive Control1 Intervention
Community Control subjects will not receive intervention.
Group II: Brain Injury Patients - no interventionActive Control1 Intervention
Brain injury patients receiving residential standard of care post-acute neurorehabilitation.
Group III: Brain Injury Patients - inulin interventionActive Control1 Intervention
Brain injury patients receiving residential standard of care post-acute neurorehabilitation plus 42 days of daily oral inulin supplementation (4g 2x daily).

Inulin is already approved in European Union, United States, Canada, Japan, China, Switzerland for the following indications:

🇪🇺
Approved in European Union as Inulin for:
  • Dietary supplement
  • Prebiotic
🇺🇸
Approved in United States as Inulin for:
  • Dietary supplement
  • Prebiotic
🇨🇦
Approved in Canada as Inulin for:
  • Dietary supplement
  • Prebiotic
🇯🇵
Approved in Japan as Inulin for:
  • Dietary supplement
  • Prebiotic
🇨🇳
Approved in China as Inulin for:
  • Dietary supplement
  • Prebiotic
🇨🇭
Approved in Switzerland as Inulin for:
  • Dietary supplement
  • Prebiotic

Find a Clinic Near You

Who Is Running the Clinical Trial?

The University of Texas Medical Branch, Galveston

Lead Sponsor

Trials
263
Recruited
55,400+

The Moody Foundation

Collaborator

Trials
5
Recruited
210+

Findings from Research

Mild traumatic brain injury (mTBI) causes significant changes in the gut microbiome, leading to dysbiosis that can worsen brain health, with these changes peaking at 1.5 months post-injury in a study involving male mice over a 3-month recovery period.
Feeding prebiotic inulin after the injury improved gut microbiome composition by increasing beneficial bacteria and restoring cerebral blood flow, suggesting that dietary interventions could enhance recovery from mTBI and may lead to new treatment options.
Inulin Supplementation Mitigates Gut Dysbiosis and Brain Impairment Induced by Mild Traumatic Brain Injury during Chronic Phase.Yanckello, LM., Fanelli, B., McCulloch, S., et al.[2023]
In a study of 46 neurocritical care patients, the enteric formula with prebiotic content (EFPC) led to significantly higher total energy, carbohydrate, protein, lipid, and fluid intake compared to the standard enteral formula (SEF), suggesting better nutritional support during critical care.
Patients receiving EFPC showed a non-significant trend towards achieving target nutritional doses more frequently and earlier, along with a significantly lower rate and faster improvement of diarrhea compared to those on SEF, highlighting potential benefits of prebiotics in enteral nutrition.
Use of standard enteral formula versus enteric formula with prebiotic content in nutrition therapy: A randomized controlled study among neuro-critical care patients.Tuncay, P., Arpaci, F., Doganay, M., et al.[2019]
In a 3-month randomized, placebo-controlled trial involving 24 obese patients, the intake of inulin-type fructans (ITF) significantly increased levels of beneficial gut bacteria, specifically Bifidobacterium, and reduced fecal calprotectin, a marker of gut inflammation.
The study suggests that ITF may help improve gut health in obese individuals by decreasing inflammation and potentially influencing gut microbiota-derived metabolites, although it did not significantly change short-chain fatty acid levels.
Prebiotic dietary fibre intervention improves fecal markers related to inflammation in obese patients: results from the Food4Gut randomized placebo-controlled trial.Neyrinck, AM., Rodriguez, J., Zhang, Z., et al.[2022]

References

Inulin Supplementation Mitigates Gut Dysbiosis and Brain Impairment Induced by Mild Traumatic Brain Injury during Chronic Phase. [2023]
Use of standard enteral formula versus enteric formula with prebiotic content in nutrition therapy: A randomized controlled study among neuro-critical care patients. [2019]
Prebiotic dietary fibre intervention improves fecal markers related to inflammation in obese patients: results from the Food4Gut randomized placebo-controlled trial. [2022]
Inulin supplementation prior to mild traumatic brain injury mitigates gut dysbiosis, and brain vascular and white matter deficits in mice. [2023]
The Prebiotic Potential of Inulin-Type Fructans: A Systematic Review. [2023]
Effect of chicory-derived inulin-type fructans on abundance of Bifidobacterium and on bowel function: a systematic review with meta-analyses. [2022]
Effects of inulin-type fructans on appetite, energy intake, and body weight in children and adults: systematic review of randomized controlled trials. [2018]
Microbiota-related effects of prebiotic fibres in lipopolysaccharide-induced endotoxemic mice: short chain fatty acid production and gut commensal translocation. [2021]
Chicory inulin enhances fermentation of 2'-fucosyllactose by infant fecal microbiota and differentially influences immature dendritic cell and T-cell cytokine responses under normal and Th2-polarizing conditions. [2023]
Inulin with different degrees of polymerization protects against diet-induced endotoxemia and inflammation in association with gut microbiota regulation in mice. [2021]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security